| Conferences |
| Duke Debates | Tumor Board | Duke Debates Archive |
The Grove Park Inn, Asheville, NC
Each year, the Duke Hematologic Malignancy Program holds a national conference with experts from Duke and around the world coming together to debate the best new approaches to the care of patients with hematologic malignancies. Primary Oncologists, hematopathologists, nurse practitioners, physician's assistants, nurses, pharmacists and support staff all benefit from this unique format which encourages audience participation in these timely discussions. With the positive growth of last year, we are expanding with the addition of focused small group sessions in pain control and complementary medicine, hematopathology, and cancer biology!
Registration for Simultaneous Sessions
Continental Breakfast
Advanced Practice Nursing and Pharmacist Program: Diffuse Large B-Cell Lymphoma Case Based Discussion
Welcome Jennifer Loftis, RN, MSN
Epidemiology, Pathophysiology and Staging Heather Brumbaugh, RN, MSN, ANP, AOCN
Standard Treatment and Expected Response Donna Adams, RN, BSN, OCN
Indications for Stem Cell Transplantation Martha Lassiter, RN, MSN
Break
New Drugs for Hematologic Malignancies Ashley M. Engemann, Pharm.D., BCOP
10:15-10:45 Oral Chemotherapy Agents: Improving
Compliance and Managing Toxicity Sally Y. Barbour, Pharm.D.,BCOP, CPP
Discovery Process for Decision Making Kristine Sullivan, EdD
Spirituality- What Does It All Mean? Jill Burleson, RN, ANP
Practical Hematopathology: Controversies and Pitfalls
Welcome Patrick Buckley, MD, PhD
Applying Genomics to the Lymphoma Patient Sandeep Dave, MD, PhD
Overview of New Tests in Molecular Mike Datto, MD, PhD
Diagnostics, Flow Cytometry, and
Cytogenetics Barbara Goodman, PhD
Break
Hematopathology Workshop: Drs. Buckley, Goodman, Lagoo & Datto
Small Cell Lymphomas: Diagnostic pitfalls
Case-based Presentation Submitted by Cases
Diagnostic Consultation and Discussion
Community Pathologists and Course Faculty
Duke Debates - Controversies in the Management of Patients with Hematologic Malignancies
The Grove Park Inn,
Lunch
Main Session
Welcome Joseph Moore, MD
Chronic Disease and Chronic Issues Moderator: David Rizzieri, MD
Chronic Lymphocytic Leukemia (CLL) Induction: William Weirda, MD, Ph.D.
How Hard to Push? (case-based discussion)
1:20-2:00 ASCO/NCCN Guidelines for Thromboprophylaxis Tom Ortel, MD, PhD
in the Cancer Patient-
Today’s Best Therapy for Chronic Myelogenous Joseph Moore, MD vs. Nelson Chao, MD, MBA
Leukemia (CML): When Induction Fails to Provide
a Cytogenetic Response
Break
Leukemia Moderator: Joseph Moore, MD
Emerging Therapies for Multiple Myeloma. William Richardson, MD vs. Cristina Gaspareto, MD
Is there an Optimal Induction Therapy for MDS Carlos DeCastro, MD
(Mylodysplastic Syndrome)?
Tumor Board Case Presentations: Drs. Moore, Chao, DeCastro & Rizzieri
Mylodysplastic Syndrome (MDS)
Elderly
Targeted Therapy Cases *** Audience Participation Highly Encouraged****
Wine and Cheese Reception
Lymphoma Moderator: Louis Diehl, MD
Breakfast
Erythropoietin biology in non-hematopoietic organs and cancer Murat Arcasoy, MD PhD
Approach to the Patient with High Risk IPI Ann Beaven, MD
(International Prognostic Index)
Lymphoma Tumor Board- Drs, Diehl, Beaven, Rizzieri, & Weirda
Maintenance Therapy in Lymphoma
Radioimmunotherapy for Low Grade Lymphoma
Initial treatment for Diffuse Large Cell Lymphoma
Measurement of Tumor Response




DHTS STRATEGIC WEB SERVICES